Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 111 participants.

Also called NCT06439758

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 111 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06439758
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06439758. Randomized; double masking; primary purpose treatment. Start 2024-08-01 (anticipated); primary completion 2025-08-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes
Condition
Diabetes Type 2
Condition
Osteoporosis
Intervention (Drug)
Metformin
Intervention (Behavioral)
Lifestyle
Lead sponsor
King Saud University (class: other)

Record details

Record id
cardio:ct-nct06439758
Content hash
256f4d5be3607033634e7418896d7173115fd8b5789d57b29e4b1fdbb1ce2ba7